ReviewGenes2024

Cardiac and Nephrological Complications Related to the Use of Antiangiogenic and Anti-Programmed Cell Death Protein 1 Receptor/Programmed Cell Death Protein 1 Ligand Therapy.

Paulina Stachyra-Strawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.